Dusa pharmaceuticals inc (DUSA)
Balance Sheet / TTM
Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Cash and cash equivalents

28,735

26,560

25,236

24,423

23,301

20,742

8,884

Marketable securities, at fair value

3,570

4,775

3,784

3,791

1,116

3,378

10,762

Accounts receivable, net of allowance for doubtful accounts of $43,000 and $50,000 in 2012 and 2011, respectively

2,772

2,636

3,353

3,729

2,231

2,157

3,225

Inventory

3,779

3,403

3,222

2,823

2,967

2,985

2,047

Prepaid and other current assets

901

1,029

1,220

1,380

754

-

1,344

Current assets of discontinued operations

-

-

0

38

-

-

203

Prepaid and other current assets

-

-

-

-

-

1,121

-

TOTAL CURRENT ASSETS

39,759

38,405

36,817

36,187

30,370

30,385

26,467

Restricted cash

176

176

175

175

175

175

174

Property, plant and equipment, net

1,654

1,783

1,836

1,601

1,521

1,575

1,582

Deferred charges and other assets

64

71

85

57

61

66

68

TOTAL ASSETS

41,655

40,437

38,915

38,022

32,129

32,202

28,293

Accounts payable

1,285

1,110

1,332

803

1,017

1,128

160

Accrued compensation

1,317

1,082

546

2,351

960

788

2,243

Other accrued expenses

2,926

3,050

3,368

2,459

2,723

2,572

1,967

Deferred revenues

-

-

-

-

0

601

712

Current liabilities of discontinued operations

161

248

319

851

-

-

383

TOTAL CURRENT LIABILITIES

5,691

5,491

5,567

6,466

4,701

5,091

5,467

Deferred revenues

893

893

897

900

908

1,822

1,917

Warrant liability

4,525

2,823

4,140

2,216

1,698

4,267

1,203

Other liabilities

137

144

150

157

161

166

181

TOTAL LIABILITIES

11,247

9,351

10,755

9,741

7,470

11,348

8,769

COMMITMENTS AND CONTINGENCIES (NOTE 9) SHAREHOLDERS' EQUITY

0

0

0

0

0

-

0

Capital Stock Authorized: 100,000,000 shares; 40,000,000 shares designated as common stock, no par, and 60,000,000 shares issuable in series or classes; of which 40,000 were designated junior Series A preferred shares. Issued and outstanding: 25,027,683 and 24,649,614 shares of common shares, no par, at September 30, 2012 and December 31, 2011, respectively

151,853

151,774

151,758

151,985

151,985

151,985

151,703

Additional paid-in capital

12,459

11,788

11,056

10,606

10,283

9,971

9,399

Accumulated deficit

-133,910

-132,489

-134,674

-134,336

-137,644

-141,150

-141,656

Accumulated other comprehensive income

5

11

18

25

33

49

77

TOTAL SHAREHOLDERS' EQUITY

30,407

31,086

28,159

28,281

24,658

20,854

19,523

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

41,655

40,437

38,915

38,022

32,129

32,202

28,293